Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04313881 |
|---|---|
| Brief Title: | Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS) (ENHANCE) |
| First Submitted : | March 11, 2020 |
| First Submitted that Met QC Criteria : | March 17, 2020 |
| First Posted : | March 18, 2020 |
| Results First Submitted : | February 15, 2024 |
| Results First Posted with QC Comments : | March 13, 2024 |
| Results First Submitted that Met QC Criteria : | March 19, 2024 |
| Results First Posted : | March 21, 2024 |
| Last Update Submitted that Met QC Criteria : | March 19, 2024 |
| Last Update Posted : | March 21, 2024 |